South Asia vs Türkiye: Immunization, Hib3
South Asia
94.5%
in 2024
Türkiye
99.0%
in 2024
South Asia rank
1st
Türkiye rank
1st
Immunization, Hib3 over time
- South Asia
- Türkiye
How they compare
Türkiye currently reports 99.0% against 94.5% in South Asia, a difference of 4.5%.
Across all 18 years both countries report, Türkiye has been ahead every year.
South Asia ranks 1st and Türkiye ranks 1st of 43 groups.
Türkiye has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | South Asia | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.6% | 89.3% | 85.7% | Türkiye |
| 2010s | 50.6% | 97.3% | 46.7% | Türkiye |
| 2020s | 90.6% | 98.0% | 7.4% | Türkiye |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, South Asia or Türkiye?
- Türkiye, at 99.0% against 94.5% in South Asia as of 2024.
- What is the difference in immunization, hib3 between South Asia and Türkiye?
- 4.5%, with Türkiye ahead.
- How many years of comparable data are there for South Asia and Türkiye?
- 18 years are reported by both, from 2007 to 2024.
- How do South Asia and Türkiye rank globally for immunization, hib3?
- South Asia ranks 1st and Türkiye ranks 1st of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.